Abstract:Ferroptosis is a form of regulated necrosis associated with the iron-dependent accumulation of lipid hydroperoxides that may play a key role in the pathogenesis of degenerative diseases in which lipid peroxidation has been implicated. High-throughput screening efforts have identified ferrostatin-1 (Fer-1) and liproxstatin-1 (Lip-1) as potent inhibitors of ferroptosis - an activity that has been ascribed to their ability to slow the accumulation of lipid hydroperoxides. Herein we demonstrate that this activity likely derives from their reactivity as radical-trapping antioxidants (RTAs) rather than their potency as inhibitors of lipoxygenases. Although inhibited autoxidations of styrene revealed that Fer-1 and Lip-1 react roughly 10-fold more slowly with peroxyl radicals than reactions of α-tocopherol (α-TOH), they were significantly more reactive than α-TOH in phosphatidylcholine lipid bilayers - consistent with the greater potency of Fer-1 and Lip-1 relative to α-TOH as inhibitors of ferroptosis. None of Fer-1, Lip-1, and α-TOH inhibited human 15-lipoxygenase-1 (15-LOX-1) overexpressed in HEK-293 cells when assayed at concentrations where they inhibited ferroptosis. These results stand in stark contrast to those obtained with a known 15-LOX-1 inhibitor (PD146176), which was able to inhibit the enzyme at concentrations where it was effective in inhibiting ferroptosis. Given the likelihood that Fer-1 and Lip-1 subvert ferroptosis by inhibiting lipid peroxidation as RTAs, we evaluated the antiferroptotic potential of 1,8-tetrahydronaphthyridinols (hereafter THNs): rationally designed radical-trapping antioxidants of unparalleled reactivity. We show for the first time that the inherent reactivity of the THNs translates to cell culture, where lipophilic THNs were similarly effective to Fer-1 and Lip-1 at subverting ferroptosis induced by either pharmacological or genetic inhibition of the hydroperoxide-detoxifying enzyme Gpx4 in mouse fibroblasts, and glutamate-induced death of mouse hippocampal cells. These results demonstrate that potent RTAs subvert ferroptosis and suggest that lipid peroxidation (autoxidation) may play a central role in the process.

Peroxisome proliferator-activated receptor δ rescues xCT-deficient cells from ferroptosis by targeting peroxisomes

PPARα alleviates iron overload‐induced ferroptosis in mouse liver

A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria

Copper-dependent autophagic degradation of GPX4 drives ferroptosis

Intracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis in Vivo

On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death

CGI1746 Targets Σ1r to Modulate Ferroptosis Through Mitochondria-Associated Membranes

Coenzyme A protects against ferroptosis via CoAlation of thioredoxin reductase 2

Repression of ferroptotic cell death by mitochondrial calcium signaling

Protein CoAlation on TXNRD2 regulates mitochondrial thioredoxin system to protect against ferroptosis

A potent GPX4 degrader to induce ferroptosis in HT1080 cells

CGI1746 targets σ 1 R to modulate ferroptosis through mitochondria-associated membranes

Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis

Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro

Proteomic analysis of ferroptosis pathways reveals a role of CEPT1 in suppressing ferroptosis

Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis

Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis

A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4

Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway

PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis

Peroxisome proliferator-activated receptor-γ ameliorates neuronal ferroptosis after traumatic brain injury in mice by inhibiting cyclooxygenase-2